HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS
申请人:CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD.
公开号:US20170253614A1
公开(公告)日:2017-09-07
A series of hepatitis C virus (HCV) inhibitors and compositions and applications thereof in the preparation of drugs for treating chronic HCV infection. Especially, a series of compounds that are used as NS5A inhibitors, and compositions and uses thereof in the preparations of drugs.
The 15N NMR spectra of a series of derivatives of 2‐amino‐2‐deoxy‐β‐D‐glucopyranose and dipeptides or secondary amines were recorded. In the dipeptide derivatives the chemical shift of nitrogen atom N‐1 (linked to sugar) is essentially unchanged and the shifts of nitrogen atoms N‐3 and N‐6 are determined by the nature of the R1 and R2 substituents at C‐α carbon of the amino acid unit. The highest shielding